AstraZeneca said a study found its Covid-19 antibody treatment cut the risk of severe disease when given soon after symptoms develop, paving the way for its broader use
As fourth doses of Covid vaccines roll out, some are questioning whether the general population needs them. At the center of this debate are mysterious T-cells. WSJ’s Daniela Hernandez explains T-cells’ role in Covid immunity and how they relate to antibodies. Illustration: Laura KammermannAstraZeneca PLC said a study found its Covid-19 antibody treatment cut the risk of severe disease when given soon after symptoms develop, paving the way for its broader use.
The development comes at a time when the use of antibody treatments—once a mainstay for patients at high risk of developing severe Covid-19—has been complicated by the rise of the Omicron family of variants, which are less susceptible to some of the treatments. The treatments also face fierce competition from the
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Millions of COVID-19 Vaccines WastedMillions of COVID vaccines doses have been wasted in the United States according to data from the Centers for Disease Control and Prevention.
Read more »
Millions of COVID-19 Vaccines WastedMillions of COVID vaccines doses have been wasted in the United States according to data from the Centers for Disease Control and Prevention.
Read more »
COVID-19 cases rising again in WashingtonOfficials said it may be time to bring back some of the precautions from the beginning of the pandemic to help stem this new spread.
Read more »
J&J Says It Plans to End Covid-19 Vaccine Supply Deal With Emergent BioSolutionsJ&J said it plans to end a Covid-19 vaccine manufacturing contract with Emergent BioSolutions, saying the manufacturer had breached their agreement. The disclosure came after Emergent sued J&J for breach of contract
Read more »
STUDY: Top 10 careers with biggest growth potential, post COVID-19While COVID-19 is still among us, a study by UC San Diego's Center for Research and Evaluation Monday released a list of the top 10 professions with the biggest growth potential in a post or with-COVID world.
Read more »
US has wasted more than 82 million COVID-19 vaccine doses: reportMillions of COVID-19 vaccine doses have been discarded during the pandemic as the Biden administration urges Americans to get booster shots
Read more »